Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.
Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Indapta Therapeutics is a privately held biotechnology company.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).
PepGen is empowering nucleic acid therapeutics to go the distance.
Metalex Commodities is a commodity trading company that specializes in the export of metal ores and concentrates.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Robotic microfactories for building net-zero homes 2x faster, 2x cheaper with 10x lower carbon
RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 22 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post Ipo Equity round. RA Capital Management's total known invested capital is $44.2B.
RA Capital Management's average investment size is $123.1M across its portfolio of 453 companies.
Recent RA Capital Management portfolio additions include Biohaven Pharmaceutical, Azalea Therapeutics, Seres Therapeutics, Hemab, Tango Therapeutics. These companies were founded in 2020 or later.